2013-05799. Manufacturer of Controlled Substances, Notice of Registration; Johnson Matthey, Inc., Pharmaceuticals Materials  

  • Start Preamble

    By Notice dated November 1, 2012, and published in the Federal Register on November 9, 2012, 77 FR 67397, Johnson Matthey, Inc., Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 19428, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

    DrugSchedule
    Gamma Hydroxybutyric Acid (2010)I
    Amphetamine (1100)II
    Methylphenidate (1724)II
    Codeine (9050)II
    Oxycodone (9143)II
    Diphenoxylate (9170)II
    Hydrocodone (9193)II
    Meperidine (9230)II
    Methadone (9250)II
    Methadone intermediate (9254)II
    Morphine (9300)II
    Thebaine (9333)II

    The company plans to manufacture the listed controlled substances in bulk for distribution and sale to its customers.

    The Thebaine (9333) will also be used to manufacture other controlled substances for sale in bulk to its customers.

    No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc., Pharmaceuticals Materials to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc., Pharmaceuticals Materials to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history.

    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

    Start Signature

    Dated: February 27, 2013.

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

    End Signature End Preamble

    [FR Doc. 2013-05799 Filed 3-12-13; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
03/13/2013
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
2013-05799
Pages:
15975-15975 (1 pages)
PDF File:
2013-05799.pdf